SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-017395
Filing Date
2014-03-24
Accepted
2014-03-24 17:22:51
Documents
4
Period of Report
2014-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v372457_8k.htm 8-K 32479
2 EXHIBIT 3.1 v372457_ex3-1.htm EX-3.1 83339
3 EXHIBIT 10.1 v372457_ex10-1.htm EX-10.1 527289
4 EXHIBIT 10.2 v372457_ex10-2.htm EX-10.2 103572
  Complete submission text file 0001144204-14-017395.txt   747990
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 14713935
SIC: 2834 Pharmaceutical Preparations